Navigation Links
Analyses Find Type 2 Diabetes Patients Treated with BYDUREON™ Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 2011
Date:9/12/2011

elease for injectable suspension. It is an investigational medication for type 2 diabetes designed to deliver continuous therapeutic levels of exenatide in a single weekly dose. BYDUREON is a once-weekly formulation of exenatide, the active ingredient in BYETTA, which has been available in the U.S. since June 2005 and is used in more than 70 countries worldwide to improve glycemic control in adults with type 2 diabetes. BYDUREON received marketing authorization in the European Union in June 2011 and is currently under review in the U.S., with a Prescription Drug User Fee Action (PDUFA) date of January 28, 2012. It is available in the UK and will launch in other major European countries as soon as possible.

Study and Presentation Details:
DURATION-3
Presentation Number 778
Poster Session 062--Exenatide: twice daily to once weekly
Tuesday, Sept. 13, 2011, 1:30-2:30 p.m. Western European Summer TimeThe initial trial was an open-label study of 467 patients not achieving adequate glucose control using metformin therapy alone or in combination with a sulfonylurea. Subjects were randomized to receive treatment with BYDUREON or titrated doses of Lantus. The primary endpoint was reduction in A1C; secondary endpoints included change in body weight along with other parameters of glucose control, safety endpoints including hypoglycemia, cardiovascular risk biomarkers and patient-reported outcomes.

The comparator-controlled extension study evaluated sustained use of BYDUREON or Lantus and is ongoing. Interim results include data from patients (n=346) who entered the extension study and remained on their initial therapy for a total of 84 weeks. Post-hoc analyses examined changes in systolic blood pressure, diastolic blood pressure, LDL cholesterol, HDL cholesterol, triglycerides, total cholesterol and high-sensitivity C-reactive protein in patients with abnormal baseline values; correlat
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Alkermes, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
5. New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG
6. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
7. New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
8. Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
9. Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
10. New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes
11. Results and Additional Analyses From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 2014  Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... pain, announced today that Sergio Traversa , chief ... MICRO "MAIN Event" Micro-Cap Growth Conference on Wednesday, December ... Luxe Sunset Bel Air Hotel, which is located at ... . The presentation is scheduled for ...
(Date:11/24/2014)... Nov. 24, 2014  AiCure, an artificial intelligence ... to monitor medication ingestion, has announced the start ... intervene with patients receiving medication as maintenance therapy ... from prescription opiates have quadrupled in the last ... year than heroin, cocaine and benzodiazepines combined. Overall, ...
(Date:11/24/2014)... , Nov. 24, 2014  GlySens Incorporated announced ... million dollar grant from the National Institute of Diabetes ... the National Institutes of Health (NIH).  The grant is ... second generation ICGM™ long term implantable glucose monitoring system.  ... and enrollment is expected to begin before the end ...
Breaking Medicine Technology:Relmada Therapeutics To Present At LD MICRO Conference 2Can artificial intelligence solve the $55 billion problem of opioid abuse? 2GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health 2
... Inc. ("Vasomedical") (OTC Bulletin Board: VASO ), ... results of the three months ended November 30, 2010. ... of cardiovascular diseases. In addition, the Company, through a ... operations on July 1, 2010 under its sales representative ...
... and HYDERABAD, India, Jan. 18, 2011 Cambrex Corporation ... Danish Medicines Agency (DKMA) has issued a Certificate of ... in Hyderabad, India, following an audit conducted in October ... Health Authorities and by authorities of several other countries ...
Cached Medicine Technology:Vasomedical Reports Financial Results for the Quarter Ended November 30, 2010 2Vasomedical Reports Financial Results for the Quarter Ended November 30, 2010 3Vasomedical Reports Financial Results for the Quarter Ended November 30, 2010 4
(Date:11/26/2014)... 26, 2014 Senior Planning Services, providing ... a nonprofit organization providing the adult demographic education ... help seniors navigate the rough seas of applying for ... seniors on the topic of Medicaid eligibility and proper ... process of applying for this coverage. , Senior ...
(Date:11/26/2014)... 2014 Medical suction and vacuum products ... 5. This score represents steady growth in the price ... 2014 as a result of swelling demand for healthcare ... are largely considered nondiscretionary. IBISWorld market research analyst, Anna ... some degree of flexibility, given the low level of ...
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, Jennifer E. Hill, ... from The American Association of Nurse Practitioners ... nurse practitioners. The Distinguished Preceptorship Award recognizes the ... significant contribution toward increasing the awareness and acceptance ... (AANP) is the largest full-service national professional membership ...
(Date:11/26/2014)... (HealthDay News) -- The number of emergency department visits in ... to a record 136 million in 2011, according to the ... also showed that fewer people were going to ERs with ... needing medical care within two hours of arriving at the ... the research. Sixty percent of patients arrived at the ...
(Date:11/24/2014)... 24, 2014 Recently, Fecbek.com ( http://www.fecbek.com ), ... its website and introduced the history of the Black Friday ... the day after Thanksgiving? It is the Black Friday! It ... of November 11th in China. However, not everyone knows the ... basic information about this special day. , The fourth Friday ...
Breaking Medicine News(10 mins):Health News:Senior Planning Services Teams Up with SeniorNet To Educate Seniors On Medicaid Planning 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:ER Visits on the Rise, Study Reports 2
... Provide New Yorkers with Free HIV/AIDS TestingNEW YORK, May 14 ... The Duane Reade Charitable Foundation has doubled its support from ... of AIDS Walk New York (AWNY). AWNY raises funds ... service organizations in the New York tri-state area. AWNY ...
... OnCare Reduces Paperwork, Allows for Stronger ManagementMOUNTAIN VIEW, ... analysis of the mobile resource management (MRM) market, ... the recipient of the "2009 North American Home ... has translated the location, tracking, and management capabilities ...
... CyberPower,s innovative, high performance UPS product line and is expected to ... ... Minneapolis, MN (PRWEB) May 14, 2009 -- CyberPower Systems, Inc. ... today announced a distribution agreement with Tech Data Corporation (NASDAQ: TECD) ...
... LONDON, May 14 Pre-hospital emergency care in ... key factors improving the quality of healthcare across ... due to epidemiological reasons, accidents and terrorist activities, ... healthcare providers. To ensure efficiency and enhance ambulance ...
... action in the best interests of the people ... accounts?COLLEYVILLE, Texas, May 14 Our leading health ... e-cigarettes. This parade is lead by the backdoor ... conscious senator, who has taken well over $100,000 ...
... Court Justice Kathleen Blatz, investment bank partner Kevin Green join ... The Blue Cross and Blue Shield of Minnesota (Blue Cross) ... and Kevin Green. Kathleen Blatz is a former chief justice ... eight years of leadership. Currently an attorney at law specializing ...
Cached Medicine News:Health News:Duane Reade Announces Premier-Level Sponsorship of AIDS Walk New York 2Health News:Frost & Sullivan Cites Gearworks for Creativity and Customer Service in the Home Healthcare Market 2Health News:Frost & Sullivan Cites Gearworks for Creativity and Customer Service in the Home Healthcare Market 3Health News:CyberPower Systems Expands Market Presence by Signing Distribution Agreement with Tech Data 2Health News:CyberPower Systems Expands Market Presence by Signing Distribution Agreement with Tech Data 3Health News:Focus on Rapid Medical Response to Improve the Quality of Healthcare and Drive the Ambulance Services Market in Europe, According to Frost & Sullivan 2Health News:Focus on Rapid Medical Response to Improve the Quality of Healthcare and Drive the Ambulance Services Market in Europe, According to Frost & Sullivan 3Health News:Focus on Rapid Medical Response to Improve the Quality of Healthcare and Drive the Ambulance Services Market in Europe, According to Frost & Sullivan 4Health News:Proposed E-Cigarette Ban Pushed in the Name of America's Health Actually a Backdoor Boost to Pharmaceutical Companies 2Health News:Blue Cross Board of Trustees Elects Two New Members 2Health News:Blue Cross Board of Trustees Elects Two New Members 3
... eyewear designs with children in mind, making ... and stay-put cable temples. Its not surprising ... Research as the best selling childrens collection ... so popular is its ability to keep ...
Inquire...
... new GUCCI DONNA eyewear collection celebrates the ... a vintage yet contemporary feel, the unmistakable ... new GUCCI UOMO optical and sunglass collection, ... classic lines with cutting-edge design that is ...
Inquire...
Medicine Products: